PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Cardiovascular disease medications underused globally

Study shows lack of progress managing future adverse health events in patients with cardiovascular disease, largely due to patients not receiving recommended medications

2025-02-03
(Press-News.org) Secondary prevention medications for cardiovascular diseases (CVD) are underused globally and additional strategies to increase their use are needed to improve CVD management and reduce premature mortality rates, according to study published today in JACC, the flagship journal of the American College of Cardiology. The study observed participants with CVD from 17 countries over 12 years and found that medication use remains low with little improvement.

Secondary prevention of CVD focuses on preventing further health problems in people already diagnosed with CVD. This includes managing risk factors through lifestyle changes, medications and treatments. Without intervention, these patients are at a higher risk of death, future heart attacks, strokes and heart failure. Leading international organizations, such as the World Health Organization (WHO) and the United Nations (UN), have issued targets over the last decade to reduce premature mortality from CVD through improved treatments and medications.

“After examining the progress of medication use for secondary cardiovascular (CVD) prevention, our research indicates that there continues to be substantial under-utilization of these medications with little improvement over time, and that global targets are unlikely to be reached,” said Dr. Philip Joseph, lead author of the study and scientist at the Population Health Research Institute (PHRI) – a joint institute of McMaster University and Hamilton Health Sciences, Canada.

The PHRI Prospective Urban Rural Epidemiology (PURE) study, a multi-national, community-based, prospective cohort study, analyzed over 11,000 participants with diagnosed CVD between 30-70 years of age over 12 years. Participants were from communities in countries at different income levels and were selected based on criteria representing urban and rural areas.

Participating countries include: (income level based on their World Bank classification at their time of starting the study)

High-income: Canada, Sweden, United Arab Emirates Upper-middle-income: Argentina, Brazil, Chile, Malaysia, Poland, South Africa, Türkiye Lower-middle-income: China, Colombia, Iran Low-income: Bangladesh, India, Pakistan, Zimbabwe Research results showed that medication use for secondary CVD prevention varied by country income level and was lower at the last study visit compared to the first visit in every income level except for upper-middle-income countries.

Overall, the use of at least one medication for secondary prevention started at 41.3% at the baseline study visit, peaked at 43.1%, and dropped to 31.3% at the last study visit. In high-income countries, use declined from 88.8% to 77.3%. In upper-middle-income countries, it rose from 55% to 61.1%. In lower-middle-income countries, it began at 29.5%, peaked at 31.7%, and fell to 13.4%. In low-income countries, it increased from 20.8% to a peak of 47.3%, then declined to 27.5%. Use of three or more proven medication classes for secondary prevention was substantially lower in all country income levels.

“Our findings suggest that current secondary prevention strategies continue to leave the majority of people with CVD either untreated or undertreated and highlight the general lack of progress being made to increase the use of secondary CVD prevention medications in most parts of the world,” Joseph said.

“This landmark study underscores an immense opportunity to improve global cardiovascular health,” said Harlan M. Krumholz, MD, SM, Harold H. Hines Jr. Professor at Yale School of Medicine and Editor-in-Chief of JACC. “It is unacceptable that so many individuals worldwide who have already experienced heart disease are not receiving readily available and inexpensive treatments that could save lives and prevent further events. We have the tools to bridge this gap in care now—and we must act urgently.”

Limitations of the study include the analysis of only seventeen countries, although they were from a broad range of geographical areas as well as levels of economic development.  The potential for participants to have underestimated their medication use may have caused limitations, including the unknown extent to which changes in cohort demographics, CVD duration or severity impacted variations in medication use over time. Lastly, the COVID-19 pandemic restricted the ability to conduct research in some countries during part of the last follow up visit cycle.

For an embargoed copy of the study, please contact Olivia Walther, American College of Cardiology Media Relations Manager for JACC, at owalther@acc.org.

The American College of Cardiology (ACC) is the global leader in transforming cardiovascular care and improving heart health for all. As the preeminent source of professional medical education for the entire cardiovascular care team since 1949, ACC credentials cardiovascular professionals in over 140 countries who meet stringent qualifications and leads in the formation of health policy, standards and guidelines. Through its world-renowned family of JACC Journals, NCDR registries, ACC Accreditation Services, global network of Member Sections, CardioSmart patient resources and more, the College is committed to ensuring a world where science, knowledge and innovation optimize patient care and outcomes. Learn more at www.ACC.org or follow @ACCinTouch.

The ACC’s JACC Journals rank among the top cardiovascular journals in the world for scientific impact. The flagship journal, the Journal of the American College of Cardiology (JACC) — and specialty journals consisting of JACC: Advances, JACC: Asia, JACC: Basic to Translational Science, JACC: CardioOncology, JACC: Cardiovascular Imaging, JACC: Cardiovascular Interventions, JACC: Case Reports, JACC: Clinical Electrophysiology and JACC: Heart Failure — pride themselves on publishing the top peer-reviewed research on all aspects of cardiovascular disease. Learn more at JACC.org.

###

 

END



ELSE PRESS RELEASES FROM THIS DATE:

Amazon Pharmacy's RxPass program improves medication adherence, helps prime members save money, study finds

Amazon Pharmacys RxPass program improves medication adherence, helps prime members save money, study finds
2025-02-03
Approximately half of all Americans do not take their medication as prescribed by their doctor. This medication non-adherence causes an estimated 125,000 additional deaths and as much as $300 billion a year in additional medical appointments, emergency department visits, and hospitalizations. A new study published in the Journal of the American Medical Association (JAMA) Network Open finds Amazon Pharmacy’s subscription service for common medications, RxPass, leads to significant improvements in medication adherence while reducing out-of-pocket costs for patients. This first-of-its-kind study evaluated the potential of subscription models to support prescription medication access ...

Tufts University School of Medicine, ATI Physical Therapy launch first-of-its-kind collaboration to make physical therapy education and career advancement more accessible and affordable

Tufts University School of Medicine, ATI Physical Therapy launch first-of-its-kind collaboration to make physical therapy education and career advancement more accessible and affordable
2025-02-03
With demand for physical therapy services projected to increase 27 percent by 2030, Tufts University School of Medicine (TUSM) and ATI Physical Therapy (ATI), a leading provider of physical therapy services across the United States, are launching a joint initiative aimed at expanding the physical therapist workforce and making the Doctor of Physical Therapy (DPT) Programs at TUSM more accessible. As part of the first-of-its-kind collaboration, TUSM and ATI will contribute scholarships each semester for up to 45 ATI employees in TUSM’s DPT programs each academic year. The accelerated ...

Could lycopene—a plant extract—be an effective antidepressant?

2025-02-03
Emerging evidence suggests that lycopene—a natural plant extract—may have antidepressant properties. New research in Food Science & Nutrition reveals the mechanisms behind its antidepressant effects. In mice with depressive-like behaviors, brain analyses revealed impairments in the hippocampus. Lycopene treatment lessened these impairments and reversed the animals’ depressive-like traits. Lycopene treatment boosted the expression of brain-derived neurotrophic factor (BDNF), a protein with roles in many aspects of brain function. Experiments indicated that a signaling pathway involving BDNF (called the BDNF-TrkB pathway, ...

Study shows urine test for prostate cancer could be used at home

Study shows urine test for prostate cancer could be used at home
2025-02-03
Researchers at Vanderbilt and the University of Michigan have shown that a simple at-home urine test for prostate cancer screening is highly accurate. The exciting new results, published in The Journal of Urology, build upon a prior Vanderbilt study of prostate cancer screening that required a digital rectal exam.   The results are important because this could enable at-home testing and increased access to testing for patients undergoing telehealth care or living in remote areas. Traditional prostate cancer screening with PSA testing and biopsy has been shown to lead to unnecessary procedures and overdiagnosis of low-grade cancers, according to ...

Shaping future of displays: clay/europium-based technology offers dual-mode versatility

Shaping future of displays: clay/europium-based technology offers dual-mode versatility
2025-02-03
The world of display technology is on the cusp of a transformative breakthrough, with electrochemical stimuli-responsive materials gaining more attraction. Based on external stimuli, such as low voltage, these materials can instantaneously undergo electrochemical reactions. These electrochemical reactions can result in the production of different colors, revolutionizing the age of display solutions. An electrochemical system consists of electrodes and electrolytes. Combining the luminescent and coloration molecules on the electrodes instead of the electrolyte can offer higher efficiencies and stability for display devices.   To this end, a research team ...

Optimizing ADHD treatment: revealing key components of cognitive–behavioral therapy

Optimizing ADHD treatment: revealing key components of cognitive–behavioral therapy
2025-02-03
Attention-deficit hyperactivity disorder (ADHD) is a well-known neurodevelopmental disorder that affects the brain's ability to regulate attention and control impulses. It poses many challenges to those affected, typically making it difficult for them to sustain focus, follow through with instructions, and maintain a calm and restful state. As one of the most common neurodevelopmental disorders, ADHD impacts individuals throughout their lives, creating a breadth of social, emotional, academic, and workplace challenges. Despite its high ...

Breaking barriers in thioxanthone synthesis: a double aryne insertion strategy

Breaking barriers in thioxanthone synthesis: a double aryne insertion strategy
2025-02-03
Thioxanthones are fascinating organic compounds that have found their way into many industrial and everyday applications. In the printing industry, for example, they help inks dry faster when exposed to light thanks to their light-absorption properties, making the printing process quicker and more efficient. Some thioxanthones have been developed into FDA-approved drugs used to treat parasitic infections and cancer. Additionally, their effectiveness as photocatalysts has led some researchers to explore their potential as stabilizers against electrical breakdown. Thioxanthones have also been ...

Houston Methodist researchers identify inhibitor drugs to treat aggressive breast cancer

2025-02-03
A national study seeking more effective treatment for deadly metaplastic breast cancer has identified two inhibitor drugs with the potential to interrupt disease progression. Houston Methodist and a team of researchers from across the country examined the biology of metaplastic breast cancer, comparing it to non-metaplastic triple negative breast cancer. They discovered metaplastic breast cancers typically exhibit two unique signaling pathways in their cell interaction. Researchers were able to disrupt these pathways using a class of inhibitors typically used to treat advanced ...

Skin disease patients show response to targeted treatment

2025-02-03
PHOENIX — Mayo Clinic researchers have identified a targeted therapy that could bring relief to people living with lichen planus, a chronic inflammatory skin condition of the skin, hair, nails, mouth and genitals. They described their findings in a study published in the Journal of Clinical Investigation that described their first-in-human, phase 2 clinical trial. The researchers identified unique molecular and cellular changes in the skin with lichen planus, particularly an overactive immune response involving specific types of T cells, a crucial immune system component. The ...

Tiny copper ‘flowers’ bloom on artificial leaves for clean fuel production

Tiny copper ‘flowers’ bloom on artificial leaves for clean fuel production
2025-02-03
Tiny copper ‘nano-flowers’ have been attached to an artificial leaf to produce clean fuels and chemicals that are the backbone of modern energy and manufacturing. The researchers, from the University of Cambridge and the University of California, Berkeley, developed a practical way to make hydrocarbons – molecules made of carbon and hydrogen – powered solely by the sun. The device they developed combines a light absorbing ‘leaf’ made from a high-efficiency solar cell material called perovskite, with a copper nanoflower catalyst, to convert carbon dioxide into useful molecules. Unlike most metal catalysts, which can only convert CO₂ into single-carbon ...

LAST 30 PRESS RELEASES:

Plan, prepare, conquer: predicting mountain accident risks with deep learning and pre-climb data

New ancient marine reptile species discovered in Germany's famous Jurassic fossil beds

Psychedelics and non-hallucinogenic analogs work through the same receptor, up to a point

​​​​​​​The Lancet: Plastic pollution is an underrecognised threat to health, experts warn as they launch a project to track plastics’ health impacts and monitor progress

The Lancet Countdown on Health and Plastics to track impact of plastic production and pollution on human health

Announcing The Lancet Countdown on Health and Plastics

Study unexpectedly finds living in rural, rather than urban environments in first five years of life could be a risk factor for developing type 1 diabetes

Editorial urges deeper focus on heart-lung interactions in pulmonary vascular disease

Five University of Tennessee faculty receive Fulbright Awards

5 advances to protect water sources, availability

OU Scholar awarded Fulbright for Soviet cinema research

Brain might become target of new type 1 diabetes treatments

‘Shore Wars:’ New research aims to resolve coastal conflict between oysters and mangroves, aiding restoration efforts

Why do symptoms linger in some people after an infection? A conversation on post-acute infection syndromes

Study reveals hidden drivers of asthma flare-ups in children

Physicists decode mysterious membrane behavior

New insights about brain receptor may pave way for next-gen mental health drugs

Melanoma ‘sat-nav’ discovery could help curb metastasis

When immune commanders misfire: new insights into rheumatoid arthritis inflammation

SFU researchers develop a new tool that brings blender-like lighting control to any photograph

Pups in tow, Yellowstone-area wolves trek long distances to stay near prey

AI breakthrough unlocks 'new' materials to replace lithium-ion batteries

Making molecules make sense: A regional explanation method reveals structure–property relationships

Partisan hostility, not just policy, drives U.S. protests

The Journal of Nuclear Medicine Ahead-of-Print Tip Sheet: August 1, 2025

Young human blood serum factors show potential to rejuvenate skin through bone marrow

Large language models reshape the future of task planning

Narrower coverage of MS drugs tied to higher relapse risk

Researchers harness AI-powered protein design to enhance T-cell based immunotherapies

Smartphone engagement during school hours among US youths

[Press-News.org] Cardiovascular disease medications underused globally
Study shows lack of progress managing future adverse health events in patients with cardiovascular disease, largely due to patients not receiving recommended medications